Atlas Trials

Ertugliflozin in Chronic Heart Failure

Clinical trial NCT04438213 · RECRUITING

Trial details

NCT number
NCT04438213
Sponsor
Yale University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure
Start date
2021-03-10
Primary completion
2025-12-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.